User-friendly syringe and injection device designs and the availability of an increasing number of drugs in pre-filled insertable and disposable cartridges are propelling the growth of prefilled syringes for self-administration. .......more

User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector pens at the expense of other drug delivery methods such as traditional syringes ......more

New materials and innovative designs have led to improved safety syringe products and more competitive price points. Safety syringes will continue to grow at the expense of traditional syringes driven by regulatory initiatives to reduce .........more

factors are giving rise to a new generation of sophisticated, application-specific disposable injection devices designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the limitations of new classes of  .......more

Advances in drug formulation and needle-free injector (NFI) device design are creating new opportunities for injectable drug delivery. User-friendly injectors that can be prefilled or accept drug cartridges are attempting to address one of the major drawbacks of earlier NFI devices. Much of the interest in  .......more

Within the injectable segment, the sands are shifting as several factors converge to drive demand for delivery methods that increase safety, compliance and ease-of-use. While the economics of traditional disposable syringe devices remain compelling, a number of companies are combining synthetic materials .....more

The convergence of socioeconomic and technology factors – the growing emphasis on drug self-administration for chronic conditions, the expected acceleration in protein- and peptide-based therapeutics, the availability of innovative dry powder inhalation devices with unique device designs - is driving .......more

Combination inhalers are relied upon by 300 million worldwide for the treatment of debilitating and life-threatening respiratory conditions. For the majority of these patients, the device in their pockets, purses, and cabinets has been and is the metered dose inhaler. Metered dose inhalers have gone through........more

Delivering drugs to the central nervous system presents unique challenges. But, drug developers and researchers have discovered that delivering CNS therapeutic drugs via inhalation mitigates several of these issues. The accessibility and vascular structure of the nose make it an attractive route for ......more

The pace and number of new inhalation delivery candidates entering the drug development pipeline is accelerating. For inhalation device suppliers and their drug partners, understanding the concerns, preferences, and limitations of consumers to self-medicate via inhalation will be the driving force for future ........more

To expand the limits of transdermal drug delivery, developers are employing microporation techniques and energy sources such as ultrasound, heat and electrical current to affect active transport through the skin. These techniques can increase the upper molecular size limit dramatically........more

Advances in synthetic materials and skin patch designs have led to transdermal drug delivery products that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Transdermal drug delivery patches.......more

Advances in the processing of materials on a micro-scale have led to the development and introduction of devices that employ very small needles – microneedles – that  have significant potential in devices for diagnostics, healthcare monitoring and drug delivery by mechanically  ........more

Growth of transdermal delivery has been restricted by the need to limit candidate drugs to molecules small enough to passively migrate through the stratum corneum, a limitation that excludes passive transdermal patches as a viable option for the growing number of protein and peptide therapeutic compounds that ..more

While the ability of recombinant protein drugs to treat previously refractory conditions continues to generate excitement and investment, the complex structure of these therapeutic substances require special formulation and delivery strategies, creating special challenges for drug developers and their formulation tech ........more

Recent recognition and industry acceptance of the unique therapeutic needs of pediatric patients has led to regulatory activity and development programs that are re-defining this market segment. The result has been a push by developers and formulators emphasizing  the creation of formulations engineered  ........more

Advances in nanotechnology that enable drugs to be delivered in ways that preserve their efficacy and to precise therapeutic targets are creating a host of opportunities for drug developers. A variety of nanostructures are being investigated as functional drug carriers for a wide range of .......more

Advances in the processing of materials on a micro-scale have led to the development and introduction of devices that employ very small needles – microneedles – that  have significant potential in devices for diagnostics, healthcare monitoring and drug delivery by mechanically  ........more

surface property optimization and solubility enhancement are enabling the creation of new formulations of both new and existing compounds. These technologies can enhance key properties such as compound solubility or bioavailability - salvaging promising NCEs that would otherwise .......more

Application-specific drug delivery devices designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the limitations of new classes of therapeutic drugs. User-friendly designs and the availability of an increasing number of drug combination products are propelling ........more